The clinical and diagnostic performance characteristics of the high sensitivity Abbott cardiac troponin I assay

Clinical Biochemistry

Volumn 48, Issue 4-5, 2015, Pages 275-281

  Collinson, P O ^a   Gaze, D ^a   Goodacre, S ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

High sensitivity; Myocardial infarction; Troponin

Indexed keywords

TROPONIN I;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CORE LABORATORY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HEALTH CARE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POPULATION DISTRIBUTION; PRIORITY JOURNAL; REFERENCE VALUE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; AGED; BIOASSAY; BLOOD; CONTROLLED STUDY; MIDDLE AGED; MYOCARDIAL INFARCTION; POINT OF CARE TESTING; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STANDARD; STANDARDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POINT-OF-CARE TESTING; PROSPECTIVE STUDIES; REFERENCE STANDARDS; TROPONIN I;

EID: 84925520164     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.12.017     Document Type: Article

References (27)

1. Melanson S.E., Morrow D.A., Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007, 128:282-286.
2. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
3. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., Czyz E., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877.
4. Eggers K.M., Oldgren J., Nordenskjold A., Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004, 148:574-581.
5. Collinson P., Goodacre S., Gaze D., Gray A. Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial. Heart 2012, 98:312-318.
6. Mills N.L., Churchhouse A.M., Lee K.K., Anand A., Gamble D., Shah A.S., et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011, 305:1210-1216.
7. Apple F.S. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009, 55:1303-1306.
8. Apple F.S., Collinson P.O. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012, 58:54-61.
9. Apple F.S., Jaffe A.S., Collinson P., Mockel M., Ordonez-Llanos J., Lindahl B., et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 2014.
10. Collinson P.O., Heung Y.M., Gaze D., Boa F., Senior R., Christenson R., et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012, 58:219-225.
11. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
12. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
13. Goodacre S.W., Bradburn M., Cross E., Collinson P., Gray A., Hall A.S. The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart 2011, 97:190-196.
14. Goodacre S., Bradburn M., Fitzgerald P., Cross E., Collinson P., Gray A., et al. The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol Assess 2011, 15:1-108.
15. Levey A.S., Coresh J., Greene T., Marsh J., Stevens L.A., Kusek J.W., et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53:766-772.
16. Collinson P., Pulkki K., Suvisaari J., Ravkilde J., Stavljenic-Rukavina A., Hammerer-Lercher A., et al. How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study. Clin Chem 2008, 54:448-449.
17. Collinson P.O., Dieijen-Visser M.P., Pulkki K., Hammerer-Lercher A., Suvisaari J., Ravkilde J., et al. Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) Study. Clin Chem 2012, 58:305-306.
18. Krintus M., Kozinski M., Boudry P., Capell N.E., Koller U., Lackner K., et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin Chem Lab Med 2014, 52:1657-1665.
19. Hamm C.W., Bassand J.P., Agewall S., Bax J., Boersma E., Bueno H., et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011, 32:2999-3054.
20. Collinson P., Gaze D., Goodacre S. Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain. Heart 2014, 100:140-145.
21. Cullen L., Mueller C., Parsonage W.A., Wildi K., Greenslade J.H., Twerenbold R., et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 2013, 62:1242-1249.
22. Than M., Aldous S., Lord S.J., Goodacre S., Frampton C.M., Troughton R., et al. A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Int Med 2014, 174:51-58.
23. Reichlin T., Schindler C., Drexler B., Twerenbold R., Reiter M., Zellweger C., et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012, 172:1211-1218.
24. Koerbin G., Abhayaratna W.P., Potter J.M., Apple F.S., Jaffe A.S., Ravalico T.H., et al. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem 2013, 46:1636-1643.
25. Eggers K.M., Johnston N., James S., Lindahl B., Venge P. Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender. Am Heart J 2014, 168:317-324.
26. Rubini G.M., Twerenbold R., Reichlin T., Wildi K., Haaf P., Schaefer M., et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. Eur Heart J 2014, 35:2303-2311.
27. Venge P., Lindahl B. Cardiac troponin assay classification by both clinical and analytical performance characteristics: a study on outcome prediction. Clin Chem 2013, 59:976-981.